Chen Huanmian, Ikeda Stephen R
Laboratory of Molecular Physiology, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland 20892-8115, USA.
J Neurosci. 2004 May 26;24(21):5044-53. doi: 10.1523/JNEUROSCI.0990-04.2004.
Human sensory neuron-specific G-protein-coupled receptors (SNSRs) are expressed solely in small diameter primary sensory neurons. This restricted expression pattern is of considerable therapeutic interest because small nociceptors transmit chronic pain messages. The neuronal function of human SNSRs is difficult to assess because rodent orthologs have yet to be clearly defined, and individual isoforms are found only in a small subset of primary sensory neurons. To circumvent this problem, we expressed human SNSR4 (hSNSR4; also known as Hs.mrgX1) in rat superior cervical ganglion (SCG), dorsal root ganglion (DRG), and hippocampal neurons using nuclear injection or recombinant adenoviruses and examined modulation of ion channels and neurotransmission using whole-cell patch-clamp techniques. BAM8-22 (a 15 amino acid C-terminal fragment of bovine adrenal medulla peptide 22), a peptide agonist derived from proenkephalin, inhibited high (but not low) voltage-activated Ca2+ current in both DRG and SCG neurons expressing hSNSR4, whereas no response was detected in control neurons. The Ca2+ current inhibition was concentration dependent and partially sensitive to Pertussis toxin (PTX) treatment. Additionally, the peptide was highly effective in modulating current arising from M-type K+ channels in SCG neurons expressing hSNSR4. In hippocampal neurons expressing hSNSR4, BAM8-22 induced presynaptic inhibition of transmission that was abolished after PTX treatment. Our data indicate that hSNSR4, when heterologously expressed in rat neurons, can be activated by an opioid-related peptide, couples to G(q/11)-proteins as well as PTX-sensitive G(i/o)-proteins, and modulates neuronal Ca2+ channels, K+ channels, and synaptic transmission.
人类感觉神经元特异性G蛋白偶联受体(SNSRs)仅在小直径初级感觉神经元中表达。这种受限的表达模式具有相当大的治疗意义,因为小伤害性感受器传递慢性疼痛信息。人类SNSRs的神经元功能难以评估,因为啮齿动物的直系同源物尚未明确界定,而且单个亚型仅在一小部分初级感觉神经元中发现。为了解决这个问题,我们使用核注射或重组腺病毒在大鼠颈上神经节(SCG)、背根神经节(DRG)和海马神经元中表达人类SNSR4(hSNSR4;也称为Hs.mrgX1),并使用全细胞膜片钳技术检查离子通道的调节和神经传递。BAM8-22(一种源自脑啡肽原的15个氨基酸的C末端片段),一种肽激动剂,在表达hSNSR4的DRG和SCG神经元中抑制高(但不是低)电压激活的Ca2+电流,而在对照神经元中未检测到反应。Ca2+电流抑制是浓度依赖性的,并且对百日咳毒素(PTX)处理部分敏感。此外,该肽在调节表达hSNSR4的SCG神经元中M型K+通道产生的电流方面非常有效。在表达hSNSR4的海马神经元中,BAM8-22诱导突触前传递抑制,PTX处理后这种抑制被消除。我们的数据表明,hSNSR4在大鼠神经元中异源表达时,可以被一种阿片类相关肽激活,与G(q/11)蛋白以及PTX敏感的G(i/o)蛋白偶联,并调节神经元Ca2+通道、K+通道和突触传递。